SYMBRAVO (meloxicam and rizatriptan)

Symbravo is a combination of meloxicam (an NSAID) and rizatriptan (a serotonin (5-HT) 1B/1D receptor agonist (triptan)), used for the acute treatment of migraine with or without aura in adults.
Limitations of Use: This therapeutic drug should only be used where a clear diagnosis of migraine has been established. It is not for the preventive treatment of migraine. It is not for the treatment of cluster headaches.

Recommended Dosage: The recommended dose of Symbravo is one tablet (containing meloxicam 20 mg and rizatriptan 10 mg) by mouth, as required for the acute treatment of migraine. Swallow the tablets whole. Do not crush, divide, or chew the tablets. This therapeutic drug can be taken with or without food.
The maximum daily dose should not exceed one tablet. The safety and effectiveness of a second dose for the same migraine attack have not been established. The safety of treating, on average, more than 7 headaches in 30 days has not been established. Use for the shortest duration consistent with individual patient treatment goals.

• There is a possibility of serious threats to the cardiovascular system such as stroke or heart attack while using Meloxicam and Rizatriptan. Long-term usage of these medications, or already having a heart condition increases the risks associated with these drugs. Patients with any cardiovascular illness should have a consultation with a specialist before consumption of these medications.
• Meloxicam has a probability of causing serious and sudden stomach ulcers, bleeding, or perforations. The elderly or those suffering from other gastrointestinal problems are more susceptible. Co-consumption of alcohol and other anti-inflammatories further enhances the risk.
• Patients suffering from heart disease may experience an irregular heartbeat while under the usage of Rizatriptan. Meloxicam can change heart rhythm in sensitive patients. Caution should be exercised for people with a history of arrhythmias. Patients feeling palpitations, dizziness, or fainting spells should seek medical assistance.
• Rizatriptan may increase the risk of strokes and transient ischemic attacks, mainly in those with high blood pressure or a known history of cerebrovascular disease. Do not use this medicine in patients with a history of stroke, as it may worsen their condition.
• Meloxicam and Rizatriptan have the potential to cause severe allergies. Symptoms can include face swelling, rashes, and breathing difficulties. Patients who have allergies to NSAIDs or triptans should refrain from using these medications and report to a healthcare facility for treatment as soon as symptoms manifest.
• The use of Rizatriptan can result in chest pain, throat discomfort, or jaw soreness which may resemble some heart conditions. This can also happen after taking the medicine. Individuals suffering from heart disease and those with unexplained discomfort should not ignore the situation and get themselves diagnosed right away.
• The use of this therapeutic drug has some risks associated with liver problems like jaundice and dark-colored urine, along with nausea. Careful prescribing is warranted for patients having liver issues. Long-term users may require routine monitoring of liver functions for any signs of liver damage.
• Meloxicam is known to cause fluid retention which is likely to worsen heart failure and edema. Patients with heart problems should watch out for new-onset symptoms such as unexplained weight gain, pronounced limb edema, and difficulty in breathing, and approach healthcare providers at the earliest.
• women, particularly those in their third trimester, should refrain from using meloxicam as it can potentially harm the fetus by causing kidney damage and heart defects. The consequence of Rizatriptan during pregnancy is unknown. Women should see a physician before use.
• Meloxicam 20 mg and Rizatriptan 10 mg can pass into breast milk, potentially affecting the infant. Breastfeeding mothers should consult their doctor before using these medications. If the baby experiences unusual symptoms, such as irritability or feeding issues, discontinuing the drug may be necessary.

What documents are required to import SYMBRAVO to India?

SYMBRAVO (meloxicam and rizatriptan) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is SYMBRAVO available in India?

SYMBRAVO (meloxicam and rizatriptan tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Symbravo in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada,
• Europe, and Australia
• Ensuring 100% transparency.

SYMBRAVO can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of SYMBRAVO (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Symbravo 20 mg/10 mg price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source SYMBRAVO (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Symbravo®?

Meloxicam and Rizatriptan is a Generic Name for the trade name drug Symbravo®.

What is the Manufacturer's Name of Symbravo®?

Symbravo® is manufactured by Axsome Therapeutics, Inc.

Is Symbravo approved by the FDA?

Yes, Symbravo® is approved by the FDA. Date of first approval: January 30, 2025.

What is the dosage and form of Symbravo® supplied?

Symbravo is supplied in Tablets: 20 mg meloxicam and 10 mg rizatriptan for oral administration.

What are the most common side effects of Symbravo® 20 mg/10 mg Tablets?

The most common side effects of Symbravo® 20 mg/10 mg tablets are dizziness and somnolence.

How much does Symbravo® 20 mg/10 mg Tablets cost in India?

Prices of Symbravo 20 mg/10 mg tablets may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Symbravo 20 mg/10 mg cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Symbravo® 20 mg/10 mg Tablets be available in SAARC countries?

Apart from Gulf countries, Symbravo® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Symbravo® Tablets in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Symbravo® 20 mg/10 mg Tablets online in India?

Yes, one can buy Symbravo 20 mg/10 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Symbravo® oral tablets through legal channels.

What are the storage conditions of Symbravo® 20 mg/10 mg Tablets?

Store tablets in the original bottle at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).